Skip to main content
. 2003 Jun 26;52(11):708–714. doi: 10.1007/s00262-003-0413-8

Table 4.

Expression (%) of CD markers on the surface of HVS-transformed T-cell lines from gastric cancer patients and healthy volunteer controls; n number of patients or volunteers tested. Only relevant results are shown. See text for a complete list of markers studied

Surface marker Cancer patients (mean ± SEM) Controls (mean ± SEM)
CD3+ 90 ± 5 (n=7)* 98 ± 1 (n=15)
CD45+ 97 ± 2 (n=7)* 100 ± 0 (n=10)
HLA-DR+ 37 ± 6 (n=7)** 69 ± 6 (n=13)

*p<0.05; **p<0.01; ***p<0.001